However, the study by Gerard et al. (2021) showed that ACE2 protein expression in lung tissue was increased in patients who died from COVID-19-related ARDS, and that the pulmonary ACE2 expression was primarily localized to endothelial cells, while the number of alveolar type II cells was reduced. The gene discussed is ACE2; the disease is COVID-19.